AquaBounty Technologies, Inc. (LON:ABTU) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
issued a press release regarding its financial and operational
results for the quarter and fiscal year ended December 31, 2016.
A copy of the press release is furnished herewith as Exhibit 99.1
and is incorporated herein by reference.
Item 2.02, including Exhibit 99.1 attached hereto, is intended to
be furnished and shall not be deemed filed for purposes of
Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section, nor shall it be
deemed incorporated by reference in any filing under the
Securities Act of 1933
forth by specific reference in such filing.
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press release issued by AquaBounty Technologies, Inc.
on March 16, 2017, furnished herewith. |
About AquaBounty Technologies, Inc. (LON:ABTU)
AquaBounty Technologies, Inc. is a biotechnology company engaged in research, development and commercialization of the commercial viability of a group of proteins, antifreeze proteins (AFPs). The Company focuses on the managing aquaculture productivity. It offers AquAdvantage Salmon (AAS), which can be grown in contained, land-based facilities. It offers AquAdvantage Salmon for land-based facilities that can be built closer to consumers to manage the need for air freight shipping and transportation. The Company’s subsidiaries include AquaBounty Canada, Inc., which operates a commercial biotechnology laboratory that conducts research and development programs related to the Company’s technologies; AquaBounty Panama, S. de R.L.; AquaBounty Farms, Inc., and AquaBounty Brasil Participacoes Ltda., which conducts commercial trials of the Company’s AquAdvantage Salmon. AquaBounty Technologies, Inc. (LON:ABTU) Recent Trading Information
AquaBounty Technologies, Inc. (LON:ABTU) closed its last trading session up +77.50 at 1,220.00 with 0 shares trading hands.